Vinracine Inj 2mg 1 Vial x 2ml is a medication that falls under the Vinca Alkaloid category. It contains the active ingredient Vincristine and is available in a 2mg strength. A prescription is generally not required for the purchase of this medication, as it is available without strict prescription requirements.
Vincristine is used in combination with other chemotherapy drugs to treat certain types of leukemia, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), as well as Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma.
Manufacturer |
Al Habib Pharmaceutical |
Country of Origin |
Pakistan |
Pack Form |
Pack of 1 Ampoule of Injection |
Product Form |
Injection |
Product Type |
Medicine |
Ingredients |
VINCRISTINE |
- Vinracine Inj 2mg is administered in accordance with a healthcare provider's guidance and treatment plan.
- It is typically used as part of combination chemotherapy for specific cancer types.
- This medication is not habit-forming, does not induce sedation, and is not intended for oral administration.
- It should be stored in a dry place at or below 25°C, protected from direct sunlight.
Vincristine may cause various side effects, which can include:
- Nausea and vomiting
- Constipation
- Neuropathy (tingling or numbness in the hands or feet)
- Hair loss (temporary)
- Muscle weakness
Q1: What is Vinracine Inj 2mg used for?
A1: Vinracine Inj 2mg, containing Vincristine, is used in combination with other chemotherapy drugs to treat specific types of leukemia (AML, ALL), Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
Q2: Is a prescription required to obtain Vinracine Inj 2mg?
A2: No, a prescription is generally not required for the purchase of Vinracine Inj 2mg. It is available without strict prescription requirements.
Q3: Are there any specific precautions to take when using Vinracine Inj 2mg?
A3: Vinracine Inj 2mg should only be administered under the guidance of a healthcare provider experienced in chemotherapy. It is not intended for oral use. Patients should be monitored for potential side effects, and any concerns should be promptly communicated to the healthcare team.